Takhzyro 150 MG

Ended Awarded

Contract number
36C24525N0930
Awardee
Awarding agency
Obligated
$36,984

Award facts

Contract value 100% obligated
$36,984.28 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Brooks, KY 40109, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award is for the pharmaceutical product TAKHZYRO 150 MG, which was awarded to Takeda Pharmaceuticals America Inc., a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited. The contract, valued at $36,984.28, is a delivery order with a firm fixed-price pricing type, and the ultimate completion date is August 27, 2025.

The contract was awarded by the Veterans Integrated Service Network 5, a civilian defense agency, and is part of the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule (FSS-61-IB) contract vehicle. Takeda Pharmaceuticals America Inc. is a key supplier of specialized medications to various federal agencies, including the Department of Veterans Affairs (VA), Department of Justice Bureau of Prisons, and Department of Defense, and this contract award demonstrates the company's ability to support critical patient care programs across different federal healthcare settings.

Quick answers

Who was awarded contract 36C24525N0930?

36C24525N0930 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 24, 2025.

How much is contract 36C24525N0930 worth?

The government has obligated $36,984 on 36C24525N0930.

Is contract 36C24525N0930 an order under another contract?

Yes. 36C24525N0930 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24525N0930 competed?

The extent of competition for 36C24525N0930 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award